A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis
暂无分享,去创建一个
Z. Ge | Xiao-Bing Zhang | V. Filippov | Chunhua Song | B. van Handel | S. Dovat | Shannalee R. Martinez | K. Payne | R. Su | P. Shiraz | Katherine R Concepcion | A. Benitez | A. J. Weldon | O. Francis | Terry-Ann M. Milford | Ineavely Baez | J. Coats | Karina Mayagoitia | Elizabeth Ginelli | C. Beldiman | K. Arogyaswamy | R. Fisher | C. Morris | Ruijun Su | A. Weldon | Ineavely Báez
[1] G. Robertson,et al. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. , 2015, Blood.
[2] M. Relling,et al. Inherited genetic variation in childhood acute lymphoblastic leukemia. , 2015, Blood.
[3] L. Robison,et al. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia , 2014, Cancer.
[4] Jun Zhong,et al. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling , 2014, Database J. Biol. Databases Curation.
[5] K. Howie,et al. Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34+ Progenitor Cells , 2013, Front. Immunol..
[6] M. Loh,et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. , 2013, Journal of the National Cancer Institute.
[7] Ning Leng,et al. EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments , 2013, Bioinform..
[8] S. Ziegler,et al. The biology of thymic stromal lymphopoietin (TSLP). , 2013, Advances in pharmacology.
[9] E. Raetz,et al. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? , 2012, Hematology. American Society of Hematology. Education Program.
[10] B. Vickery,et al. TSLP Promotes Interleukin-3-independent Basophil Haematopoiesis and Type 2 Inflammation , 2012, Pediatrics.
[11] Julie M Gastier-Foster,et al. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. , 2012, Blood.
[12] Xiaomin Lu,et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Loh,et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. , 2012, Blood.
[14] Akhilesh Pandey,et al. TSLP Signaling Network Revealed by SILAC-Based Phosphoproteomics* , 2012, Molecular & Cellular Proteomics.
[15] D. Gridley,et al. Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] T. Takai. Expression : Cellular Sources , Triggers , and Regulatory Mechanisms , 2010 .
[17] C. Mullighan. Genomic profiling of B-progenitor acute lymphoblastic leukemia. , 2011, Best practice & research. Clinical haematology.
[18] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[19] W. Leonard,et al. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7–induced signaling , 2010, Proceedings of the National Academy of Sciences.
[20] G. Reuther,et al. CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis. , 2010, Cancer research.
[21] Takashi Akasaka,et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. , 2010, Blood.
[22] J. Downing,et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. , 2010, Blood.
[23] B. Blom,et al. Thymic stromal lymphopoietin induces early human B‐cell proliferation and differentiation , 2010, European journal of immunology.
[24] Kyu-Earn Kim,et al. Increased serum thymic stromal lymphopoietin in children with atopic dermatitis , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[25] H. Cavé,et al. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia , 2010, Leukemia.
[26] E. Domany,et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. , 2010, Blood.
[27] Sebastian Krause,et al. Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function , 2010, Biological chemistry.
[28] A. Strasser,et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development , 2010, Nature Immunology.
[29] P. D. Dal Cin,et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia , 2009, Proceedings of the National Academy of Sciences.
[30] J. Downing,et al. Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia , 2009, Nature Genetics.
[31] Takashi Akasaka,et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. , 2009, Blood.
[32] L. Barsky,et al. IL-7 Dependence in Human B Lymphopoiesis Increases during Progression of Ontogeny from Cord Blood to Bone Marrow1 , 2009, The Journal of Immunology.
[33] B. Jiang,et al. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[34] G. Thomas,et al. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.
[35] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[36] Hongyue Dai,et al. Rosetta error model for gene expression analysis , 2006, Bioinform..
[37] T. Lebien,et al. Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells1 , 2005, The Journal of Immunology.
[38] Yu Wang,et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.
[39] H. D. Liggitt,et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice , 2005, Nature Immunology.
[40] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Lock,et al. Preclinical testing of antileukemic drugs using an in vivo model of systemic disease. , 2005, Methods in molecular medicine.
[42] R. Lock,et al. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. , 2004, Blood.
[43] N. Kirchhof,et al. Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesis. , 2004, Blood.
[44] M. Hofker. Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. , 2003 .
[45] B. Torok-Storb,et al. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. , 2002, Blood.
[46] J. Tisdale,et al. Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. , 2002, Blood.
[47] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[48] H. Drexler,et al. Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation , 2001, Leukemia.
[49] M. Hirai,et al. Molecular cloning of a human novel type I cytokine receptor related to δ1/TSLPR , 2001, Cytogenetic and Genome Research.
[50] R. de Waal Malefyt,et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells1 , 2001, The Journal of Immunology.
[51] M. Hirai,et al. Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR. , 2001, Cytogenetics and cell genetics.
[52] N. Copeland,et al. Molecular Cloning and Biological Characterization of a Novel Murine Lymphoid Growth Factor , 2000, The Journal of experimental medicine.
[53] D. Largaespada,et al. Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor , 2000, The Journal of experimental medicine.
[54] J. Nolta,et al. Long‐Term Cytokine Production from Engineered Primary Human Stromal Cells Influences Human Hematopoiesis in an In Vivo Xenograft Model , 1997, Stem cells.
[55] C. Paige,et al. Characterization of thymic stromal‐derived lymphopoietin (TSLP) in murine B cell development in vitro , 1996, European journal of immunology.